chenodeoxycholic acid has been researched along with Arthritis, Degenerative in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Jie, L; Li, X; Liao, T; Ma, Z; Shi, X; Wang, P; Wei, Y; Xing, R; Yang, N; Zhang, L | 1 |
Duan, Y; Gao, Y; Guo, D; He, L; Jiang, W; Jin, C; Lin, H; Qiu, W; Wang, L; Yang, R; Yao, J; Zhang, L; Zhou, Y | 1 |
Dong, J; He, CY; Miao, LY; Qin, CH; Yan, ZW; Zhao, CY | 1 |
3 other study(ies) available for chenodeoxycholic acid and Arthritis, Degenerative
Article | Year |
---|---|
GCTOF-MS Combined LC-QTRAP-MS/MS Reveals Metabolic Difference Between Osteoarthritis and Osteoporotic Osteoarthritis and the Intervention Effect of Erxian Decoction.
Topics: Animals; Chenodeoxycholic Acid; Coenzyme A; Cystine; Drugs, Chinese Herbal; Osteoarthritis; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2022 |
Obeticholic Acid Derivative, T-2054 Suppresses Osteoarthritis via Inhibiting NF-κB-Signaling Pathway.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Cartilage; Cell Line; Cell Survival; Chenodeoxycholic Acid; Cytokines; Disease Models, Animal; Gene Expression Regulation; Inflammation Mediators; Lipopolysaccharides; Male; Mice; NF-kappa B; Nitric Oxide; Osteoarthritis; RAW 264.7 Cells; Signal Transduction | 2021 |
Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis.
Topics: Animals; Anterior Cruciate Ligament; Cartilage, Articular; Chenodeoxycholic Acid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Femur; Injections, Intra-Articular; Interleukin-1beta; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Osteoarthritis; Prostaglandins E; Rabbits; Synovial Membrane; X-Ray Microtomography | 2015 |